首页> 外文期刊>Journal of tissue engineering and regenerative medicine >A novel approach to human cranial tissue regeneration and frontal sinus obliteration with an autogenous platelet-rich/fibrin-rich composite matrix: 10 patients with a 6-10year follow-up
【24h】

A novel approach to human cranial tissue regeneration and frontal sinus obliteration with an autogenous platelet-rich/fibrin-rich composite matrix: 10 patients with a 6-10year follow-up

机译:一种具有自体富含血小板/富含纤维蛋白的复合基质的人类颅骨组织再生和额窦闭塞的新方法:10位患者,进行6-10年的随访

获取原文
获取原文并翻译 | 示例
           

摘要

Advanced frontal sinus disease non-responsive to conservative therapy has been treated with fat obliteration for decades. More recently, a wide variety of autogenous, allogenic or synthetic materials have also been used. In this study we present a treatment based on totally autogenous procedures and materials that was successfully implemented in 10 patients and followed up for a period of 6-10years, to evaluate the feasibility of a new approach for the treatment of frontal sinus disease and other related cranial osseous derangements, based on regenerative medicine as an alternative to fat or other obliterating or grafting materials. Platelet-rich and -poor plasma (PRP, PPP) are set to clot with cortical shavings from the skull surface. After surgically stimulating the sinus to encourage cell chemotaxis, migration and homing, the bioactive scaffold is placed and covered with a PPP membrane and a periosteal flap. Ten patients with pathologies ranging from devastating infection to invasive tumours or trauma were treated with this regenerative procedure in a single-stage surgery. All patients had an uneventful recovery with bone formation and no complications or recurrences over the years. The application of modern principles in tissue regeneration and wound healing has resulted in a favourable outcome, with no complications or sequelae, in a series of 10 patients with advanced frontal sinus disease over a long period of time.
机译:对保守疗法无反应的晚期额窦疾病已通过脂肪消除治疗了数十年。最近,还使用了各种各样的自体,同种异体或合成材料。在这项研究中,我们提出了一种基于完全自发性程序和材料的治疗方法,该方法已在10例患者中成功实施,并随访了6至10年,以评估一种新方法治疗额窦疾病及其他相关疾病的可行性。基于再生医学的颅骨骨性疾病,可替代脂肪或其他闭塞或移植材料。富含血小板和贫血的血浆(PRP,PPP)被设置为从颅骨表面刮去皮质屑。在通过外科手术刺激鼻窦以促进细胞趋化,迁移和归巢之后,放置生物活性支架并用PPP膜和骨膜瓣覆盖。在单阶段手术中,使用该再生程序治疗了10位具有从毁灭性感染到侵袭性肿瘤或创伤的病理类型的患者。多年来,所有患者的骨形成均恢复良好,并且无并发症或复发。现代原理在组织再生和伤口愈合中的应用已在一系列10名长期患有晚期额窦疾病的患者中取得了令人满意的结果,无并发症或后遗症。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号